Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

2022424 citationsJournal Articlegreen Open Access

Authors

ClinicalTrials.gov Identifier: NCT04063163.

Good health and well-being

Published in: JAMA

Volume 328, Issue 12, pp. 1223-1223

Field-Weighted Citation Impact: 41.90